000 | 01518 a2200445 4500 | ||
---|---|---|---|
005 | 20250513135931.0 | ||
264 | 0 | _c19980330 | |
008 | 199803s 0 0 eng d | ||
022 | _a0091-2700 | ||
024 | 7 |
_a10.1002/j.1552-4604.1997.tb04272.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCallaghan, J T | |
245 | 0 | 0 |
_aOlanzapine: interaction study with imipramine. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cOct 1997 |
||
300 |
_a971-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdrenergic Uptake Inhibitors _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 | _aBenzodiazepines |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypotension, Orthostatic _xblood |
650 | 0 | 4 |
_aImipramine _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOlanzapine |
650 | 0 | 4 |
_aPirenzepine _xadverse effects |
650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
650 | 0 | 4 | _aSingle-Blind Method |
700 | 1 | _aCerimele, B J | |
700 | 1 | _aKassahun, K J | |
700 | 1 | _aNyhart, E H | |
700 | 1 | _aHoyes-Beehler, P J | |
700 | 1 | _aKondraske, G V | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 37 _gno. 10 _gp. 971-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1997.tb04272.x _zAvailable from publisher's website |
999 |
_c9473823 _d9473823 |